CA49978-3 - 0x0000000000006A33
Males & Females of Non-Childbearing Potential
Marlin
* Stipend may pay up to reflected amount.
Start Date:
March 5, 2026 - 2:00pm
End Date:
June 26, 2026 - 9:30am
Study Details
Study Number: CA49978
Group Number: 3
Study Requirement: Healthy Normal Male and Female
Stipend: up to $9,000.00
Study Criteria
Age: 19 - 55
BMI: 0 - 0
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat inflammatory bowel disease (IBD) and rheumatoid arthritis (RA).
Route of Administration: Injection IV infusion; Injection subcutaneous
Blood Draws: 16
Study Schedule
Schedule Type: Short stays with returns
Study Length: One - 5 Night Stay & 5 Returns
Screening Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 2/26/2026 |
| Wednesday | 3/4/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 2/26/2026 |
| Wednesday | 3/4/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Thursday | 3/5/2026 2:00:00 PM | Tuesday | 3/10/2026 10:00:00 AM | 1 | Lincoln |
| Return | Friday | 3/20/2026 8:20:00 AM | Friday | 3/20/2026 9:30:00 AM | 1 | Lincoln |
| Return | Friday | 4/3/2026 8:20:00 AM | Friday | 4/3/2026 9:30:00 AM | 1 | Lincoln |
| Return | Friday | 5/1/2026 8:20:00 AM | Friday | 5/1/2026 9:30:00 AM | 1 | Lincoln |
| Return | Friday | 5/29/2026 8:20:00 AM | Friday | 5/29/2026 9:30:00 AM | 1 | Lincoln |
| Return | Friday | 6/26/2026 8:20:00 AM | Friday | 6/26/2026 9:30:00 AM | 1 | Lincoln |
